mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.4 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.4 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.051 |
0.4 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |